Novo also reported 25% average weight loss in women on CagriSema in a post-hoc trial analysis, while BMO flagged Ozempic losing US share.
Recap by typeshit. Full story at ad-hoc-news.de.
Dr. Nadolsky responds to a clip from comedian @stavvybaby2 about GLP-1s, adding a doctor's view to the joke.
He calls GLP-1 drugs useful before surgery or after regain, but says surgery stays the main option for people who need large, lasting weight loss.
An anonymous poster says people put their dramatic weight loss down to their mother's death, when it was really Ozempic they wanted to keep quiet.
A short social post frames the semaglutide molecule as the start of a bigger business story for drugmakers, with a note that it is not medical advice.
The once-daily pill blocks the IL-23 receptor and helped people with moderate to severe ulcerative colitis respond more often than placebo, a new study reports.
WebMD notes that eating less on a GLP-1 can mean missing some nutrients, and suggests asking your doctor about nutrition while on the drug.
Loading…